In the first three months of his role as CEO, Chris Weston accepted a bonus of £195,000 as part of his £2.3m pay package.

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar.

Weight-loss drugs like Ozempic and Wegovy could usher in a “golden age” of medicine due to their ability to delay diseases associated with ageing.